Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › pitavastatin

pitavastatin

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of pitavastatin

19 trials tracked of pitavastatin: 15 in phase 3 or 4 and 3 with published results. The most-cited published study has 150 citations.

19Trials tracked
15Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 4 Phase 3 11 Phase 1 3 Other / NA 1
  1. Phase 3 Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults Completed · 150 cited
  2. Phase 3 PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) Completed · 34 cited
  3. Phase 4 Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir Completed · 11 cited
  4. Phase 4 Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia Completed
  5. Phase 4 A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects Completed
  6. Phase 4 Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia Completed
Show 13 more trials
  1. Phase 3 Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors Completed
  2. Phase 3 Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia Completed
  3. Phase 3 Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia Completed
  4. Phase 3 Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin Completed
  5. Phase 3 Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin Completed
  6. Phase 3 Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels Completed
  7. Phase 3 Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients Completed
  8. Phase 3 Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia Completed
  9. Phase 3 Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia Completed
  10. Phase 1 A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin Completed
  11. Phase 1 Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz Completed
  12. Phase 1 A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers Completed
  13. N/A Effects of Pitavastatin on Insulin Sensitivity and Liver Fat Completed

Showing the 19 most-cited and recently-updated of 19 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Pitavastatin lowers LDL and MACE risk in people with HIV on stable antiretroviral therapy
Infectious Disease RCT
Pitavastatin lowers LDL and MACE risk in people with HIV on stable antiretroviral therapy This cholesterol drug cuts heart risk for people with HIV
This secondary analysis of a phase 3 trial examined pitavastatin versus placebo in people with HIV aged 40 to 75 years on stable antiretrovi…
A large trial found that a daily statin cut heart risk by more than a third in people with HIV, even when their cholesterol looked fine.
May 2, 2026
PRISMA Scoping Review Examines Food-Drug Interactions in Cardiovascular and Diabetic Medications
Drug Pipeline Sys. Review
PRISMA Scoping Review Examines Food-Drug Interactions in Cardiovascular and Diabetic Medications Meals May Not Matter for Most New Heart and Diabetes Pills
This PRISMA scoping review synthesized data from 36 publications regarding food-drug interactions in cardiovascular and diabetic medications…
Most new heart and diabetes pills work the same whether you take them with food or on an empty stomach, but a few still need timing.
Frontiers Apr 27, 2026
Pitavastatin showed no difference in health-related quality of life compared with placebo in people with HIV
Infectious Disease RCT
Pitavastatin showed no difference in health-related quality of life compared with placebo in people with HIV Why Heart Risk Factors Drag Down Daily Wellbeing for People With HIV
This randomized controlled trial evaluated pitavastatin versus placebo in 733 people with HIV aged 40 to 75 years on antiretroviral therapy …
Common heart risks like smoking and high BMI hurt daily physical wellbeing for people with HIV, while statins showed no visible improvement …
Apr 13, 2026